NYSE · Financial Statements
Novo Nordisk A/S (NVO) Financial Statements
$38.83
NYSE: NVO
Market Cap $171.36B
Overview Financials Dividend Novo Nordisk A/S most recently reported annual revenue of $309.1B, net profit of $102.4B. Revenue grew at an average annual rate of 19.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $140.8B $177.0B $232.3B $290.4B $309.1B Operating Profit $58.6B $74.8B $102.6B $128.3B $127.7B Net Profit $47.8B $55.5B $83.7B $101.0B $102.4B EPS $10.37 $12.22 $18.62 $22.63 $23.03 Op Margin 41.6% 42.3% 44.2% 44.2% 41.3%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $194.5B $241.3B $314.5B $465.8B $542.9B Total Liabilities $123.8B $157.8B $207.9B $322.3B $348.9B Cash $10.7B $12.7B $14.4B $15.7B $26.5B Borrowings $26.6B $25.8B $27.0B $102.8B $131.0B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $55.0B $78.9B $108.9B $121.0B $119.1B Investing Cash Flow $-39.0B $-39.7B $-82.8B $-180.2B $-169.3B Financing Cash Flow $-19.4B $-24.1B $-29.9B $-20.2B $-1.4B Net Cash Flow $-1.5B $1.9B $1.7B $1.3B $10.8B Free Cash Flow $47.6B $64.1B $70.0B $69.7B $29.0B
Valuation & Return Ratios
Metric Value PEG Ratio 1.93 EV / EBITDA 7.05 FCF Yield 4.35% Quick Ratio 0.66 Interest Coverage 86.86 Return 1Y -27.32% Return 3Y -58.13% Return 5Y -14.90%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .